Trials / Sponsors / JN-International Medical Corporation
JN-International Medical Corporation
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Persistence of Protective Antibody Titers 12-24 Months After NmVac4-A/C/Y/W-135-DT Vaccination: Follow Up Stud Meningococcal Meningitis, Meningococcal Infections | — | 2015-06-01 |
| Completed | Immunogenicity and Safety of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Va Meningococcal Meningitis, Meningococcal Infections | Phase 2 | 2013-07-01 |
| Completed | Safety Study of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine for Men Meningococcal Meningitis, Meningococcal Infections | Phase 1 | 2011-11-01 |